New drug duo aims to cut transfusions for blood disorder patients
Disease control
Recruiting now
This study tests whether adding low-dose thalidomide to luspatercept can reduce the need for blood transfusions in adults with transfusion-dependent β-thalassemia. About 78 participants will receive either the combination or luspatercept alone. The main goal is to see if the comb…
Phase: PHASE2 • Sponsor: Rongrong Liu • Aim: Disease control
Last updated May 16, 2026 20:23 UTC